{"id":213793,"date":"2017-03-07T06:04:29","date_gmt":"2017-03-07T11:04:29","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/secukinumab-efficacy-examined-following-psoriasis-relapse-after-treatment-pause-monthly-prescribing-reference-registration.php"},"modified":"2017-03-07T06:04:29","modified_gmt":"2017-03-07T11:04:29","slug":"secukinumab-efficacy-examined-following-psoriasis-relapse-after-treatment-pause-monthly-prescribing-reference-registration","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/psoriasis-2\/secukinumab-efficacy-examined-following-psoriasis-relapse-after-treatment-pause-monthly-prescribing-reference-registration.php","title":{"rendered":"Secukinumab Efficacy Examined Following Psoriasis Relapse After Treatment Pause &#8211; Monthly Prescribing Reference (registration)"},"content":{"rendered":"<table border=\"0\" cellpadding=\"2\" cellspacing=\"7\" style=\"vertical-align:top;\"><tr><td width=\"80\" align=\"center\" valign=\"top\"><font style=\"font-size:85%;font-family:arial,sans-serif\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNGCYWbb3lV__9sdhajCBveJyvfQOQ&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779409891756&amp;ei=o5O-WMjMMoKa3QHCvYLgDA&amp;url=http:\/\/cnafinance.com\/novartis-nvs-stock-to-see-gains-on-positive-data\/14015\"><img loading=\"lazy\" decoding=\"async\" src=\"\/\/t2.gstatic.com\/images?q=tbn:ANd9GcSMQwf0J-n-ona6iTxbHdvOKLtbzqqAMJptic7EThfSHXDwldaTAlJqdcw3AQWNA6TRsmoGYwKX\" alt=\"\" border=\"1\" width=\"80\" height=\"80\" style=\"padding-left:10px; padding-right: 10px;\"><br><font size=\"-2\">CNA Finance (press release)<\/font><\/a><\/font><\/td><td valign=\"top\" class=\"j\"><font style=\"font-size:85%;font-family:arial,sans-serif\"><div style=\"padding-top:0.8em;\"><img alt=\"\" height=\"1\" width=\"1\" style=\"padding-left:10px; padding-right: 10px;\"><\/div><div class=\"lh\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNH8ZWMIT7TyaUILZ_Gy1xyi_8zmAA&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779409891756&amp;ei=o5O-WMjMMoKa3QHCvYLgDA&amp;url=http:\/\/www.empr.com\/news\/psoriasis-area-severity-index-secukinumab-cosentyx-novartis\/article\/642298\/\"><b>Secukinumab Efficacy Examined Following <b>Psoriasis<\/b> Relapse After Treatment Pause<\/b><\/a><br><font size=\"-1\"><b><font color=\"#6f6f6f\">Monthly Prescribing Reference (registration)<\/font><\/b><\/font><br><font size=\"-1\">Patients with moderate to severe plaque <b>psoriasis<\/b> rapidly regained clear or almost clear skin, as adjudged by the <b>Psoriasis<\/b> Area Severity Index, after treatment with secukinumab (Cosentyx; Novartis) following relapse during a treatment pause. The new&nbsp;...<\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNG3OxsdGltmA6rCf8mbyCnDU1fk8Q&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779409891756&amp;ei=o5O-WMjMMoKa3QHCvYLgDA&amp;url=http:\/\/finance.yahoo.com\/news\/novartis-cosentyx-shows-almost-psoriasis-063000196.html\">Novartis' Cosentyx shows almost all <b>psoriasis<\/b> patients rapidly regain skin clearance following a treatment pause<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>Yahoo Finance<\/nobr><\/font><\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNH_jWTf0ixf4jyJQOgtFnVFPaqrmQ&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779409891756&amp;ei=o5O-WMjMMoKa3QHCvYLgDA&amp;url=https:\/\/www.ptcommunity.com\/wire\/novartis-cosentyx-shows-almost-all-psoriasis-patients-rapidly-regain-skin-clearance-following\">Novartis' Cosentyx shows almost all <b>psoriasis<\/b> patients rapidly regain skin clearance following a treatment pause<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>P&amp;T Community<\/nobr><\/font><\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNGQx3lKF1cneKLiE_bTHtHguJCz5Q&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779409891756&amp;ei=o5O-WMjMMoKa3QHCvYLgDA&amp;url=http:\/\/seekingalpha.com\/news\/3248724-novartis-cosentyx-effective-clearing-skin-psoriasis-patients-following-relapse\">Novartis' Cosentyx effective in clearing skin in <b>psoriasis<\/b> patients following relapse<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>Seeking Alpha<\/nobr><\/font><\/font><br><font size=\"-1\" class=\"p\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNHnNczvf6bxRvc3khjd4ZaK7jN0OQ&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779409891756&amp;ei=o5O-WMjMMoKa3QHCvYLgDA&amp;url=http:\/\/www.econotimes.com\/ABLYNXS-PARTNER-MERCK-KGaA-HAS-PRESENTED-NEW-DATA-FROM-A-PHASE-Ib-PSORIASIS-STUDY-OF-THE-BI-SPECIFIC-ANTI-IL-17A-F-NANOBODY-AT-THE-ANNUAL-AAD-CONFERENCE-573285\"><nobr>EconoTimes<\/nobr><\/a>&nbsp;-<a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNGCYWbb3lV__9sdhajCBveJyvfQOQ&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779409891756&amp;ei=o5O-WMjMMoKa3QHCvYLgDA&amp;url=http:\/\/cnafinance.com\/novartis-nvs-stock-to-see-gains-on-positive-data\/14015\"><nobr>CNA Finance (press release)<\/nobr><\/a><\/font><br><font class=\"p\" size=\"-1\"><a class=\"p\" href=\"http:\/\/news.google.com\/news\/more?ncl=dGv1eWAMvkOHX6MGHb9DkwKqV4ArM&amp;authuser=0&amp;ned=us\"><nobr><b>all 7 news articles&nbsp;&raquo;<\/b><\/nobr><\/a><\/font><\/div><p><\/p><\/font><\/td><\/tr><\/table><p><!-- Auto Generated --><\/p><p>Here is the original post:<\/p><p><a target=\"_blank\" href=\"http:\/\/www.empr.com\/news\/psoriasis-area-severity-index-secukinumab-cosentyx-novartis\/article\/642298\/\" title=\"Secukinumab Efficacy Examined Following Psoriasis Relapse After Treatment Pause - Monthly Prescribing Reference (registration)\">Secukinumab Efficacy Examined Following Psoriasis Relapse After Treatment Pause - Monthly Prescribing Reference (registration)<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p> CNA Finance (press release) Secukinumab Efficacy Examined Following Psoriasis Relapse After Treatment Pause Monthly Prescribing Reference (registration) Patients with moderate to severe plaque psoriasis rapidly regained clear or almost clear skin, as adjudged by the Psoriasis Area Severity Index, after treatment with secukinumab (Cosentyx; Novartis) following relapse during a treatment pause. The new&nbsp;.. <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/psoriasis-2\/secukinumab-efficacy-examined-following-psoriasis-relapse-after-treatment-pause-monthly-prescribing-reference-registration.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[182497],"tags":[],"class_list":["post-213793","post","type-post","status-publish","format-standard","hentry","category-psoriasis-2"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/213793"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=213793"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/213793\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=213793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=213793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=213793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}